This refers to the structured administration and subsequent cessation of external, non-naturally produced compounds, often synthetic hormones or performance-enhancing substances, in cyclical patterns to manage physiological adaptation and mitigate long-term suppression of endogenous production. It is a pharmacological strategy demanding precise timing relative to natural endocrine rhythms. Clinically, this practice carries significant risk if not managed under expert supervision.
Origin
The term originates primarily from performance optimization communities and the study of pharmacokinetics related to synthetic anabolic agents. It describes a strategy developed to manipulate physiological outcomes while attempting to preserve some level of native endocrine function. The cycling aspect is a direct response to the body’s inherent feedback mechanisms.
Mechanism
The mechanism involves introducing supra-physiological levels of an exogenous agent, which typically suppresses the hypothalamic-pituitary-gonadal (HPG) axis via negative feedback. Cycling is an attempt to introduce periods where the HPG axis can partially recover or remain active before subsequent suppression. Successful management requires understanding the half-life of the compound and the recovery kinetics of the native endocrine glands.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.